UroGen Pharma Ltd. (LON:0XOD)
London flag London · Delayed Price · Currency is GBP · Price in USD
14.85
+0.98 (7.07%)
At close: Jun 18, 2025

UroGen Pharma Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
509359363170157292
Upgrade
Market Cap Growth
-2.63%-1.24%113.84%7.95%-46.00%-44.84%
Upgrade
Enterprise Value
45425432115277202
Upgrade
Last Close Price
11.028.6311.666.737.0218.69
Upgrade
PS Ratio
7.164.975.603.184.4433.74
Upgrade
PB Ratio
-14.15-51.05-7.10-2.2925.344.13
Upgrade
P/TBV Ratio
----25.344.13
Upgrade
EV/Sales Ratio
6.663.524.952.852.1823.36
Upgrade
Debt / Equity Ratio
-2.72-14.19-1.54-1.120.180.03
Upgrade
Asset Turnover
0.410.390.530.500.400.07
Upgrade
Inventory Turnover
1.281.191.871.671.52-
Upgrade
Quick Ratio
5.135.594.884.714.515.09
Upgrade
Current Ratio
5.656.015.425.395.115.39
Upgrade
Return on Equity (ROE)
-----211.55%-92.88%
Upgrade
Return on Assets (ROA)
-29.80%-25.77%-26.10%-38.69%-47.72%-46.29%
Upgrade
Return on Capital (ROIC)
-96.25%-79.15%-179.24%-479.55%-105.88%-52.96%
Upgrade
Earnings Yield
-21.05%-28.23%-22.08%-53.60%-51.98%-32.27%
Upgrade
FCF Yield
-16.33%-21.60%-16.54%-42.88%-40.17%-26.90%
Upgrade
Buyback Yield / Dilution
-40.86%-48.70%-26.43%-2.05%-2.60%-6.10%
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.